These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 36089410)

  • 1. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
    Guo J; Huang L
    Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy.
    Chen R; Liu M; Jiang Q; Meng X; Wei J
    Front Immunol; 2023; 14():1121603. PubMed ID: 37153627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoformulations of chemotherapeutic activators of the cGAS-STING pathway in tumor chemoimmunotherapy.
    Wang L; Yu Z; Zhang J; Guo J
    Drug Discov Today; 2024 Mar; 29(3):103892. PubMed ID: 38272174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
    Zhou S; Cheng F; Zhang Y; Su T; Zhu G
    Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Mediated STING Activation for Cancer Immunotherapy.
    Li Y; Li X; Yi J; Cao Y; Qin Z; Zhong Z; Yang W
    Adv Healthc Mater; 2023 Jul; 12(19):e2300260. PubMed ID: 36905358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy strategies that target the cGAS-STING pathway.
    Tian Z; Zeng Y; Peng Y; Liu J; Wu F
    Front Immunol; 2022; 13():996663. PubMed ID: 36353640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pleiotropic roles of cGAS-STING signaling in the tumor microenvironment.
    Li J; Bakhoum SF
    J Mol Cell Biol; 2022 Aug; 14(4):. PubMed ID: 35325182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.
    Chen Y; Li R; Duan Q; Wu L; Li X; Luo A; Zhang Y; Zhao N; Cui K; Wu W; Liu T; Wan JB; Deng L; Li G; Hou L; Tan W; Xiao Z
    Adv Sci (Weinh); 2024 Aug; 11(32):e2400149. PubMed ID: 38898748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGAS-STING pathway in cancer biotherapy.
    Wang Y; Luo J; Alu A; Han X; Wei Y; Wei X
    Mol Cancer; 2020 Sep; 19(1):136. PubMed ID: 32887628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
    Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
    Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
    Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases.
    Seok JK; Kim M; Kang HC; Cho YY; Lee HS; Lee JY
    Arch Pharm Res; 2023 Jun; 46(6):500-534. PubMed ID: 37354378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahedral DNA Nanostructure with Interferon Stimulatory DNA Delivers Highly Potent Toxins and Activates the cGAS-STING Pathway for Robust Chemotherapy and Immunotherapy.
    Zhang L; Wang Y; Karges J; Tang D; Zhang H; Zou K; Song J; Xiao H
    Adv Mater; 2023 Feb; 35(8):e2210267. PubMed ID: 36484099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic guanosine monophosphate-adenosine monophosphate synthetase/stimulator of interferon genes signaling aggravated corneal allograft rejection through neutrophil extracellular traps.
    Wei C; Huang Q; Zeng F; Ma L; Bai X; Zhu X; Gao H; Qi X
    Am J Transplant; 2024 Sep; 24(9):1583-1596. PubMed ID: 38648890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection.
    Hu Y; Chen B; Yang F; Su Y; Yang D; Yao Y; Wang S; Wu Y; Tao L; Xu T
    Autoimmun Rev; 2022 Sep; 21(9):103155. PubMed ID: 35902046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.